Thyrocare Technologies Limited (BOM:539871)
1,399.65
+14.00 (1.01%)
At close: Aug 18, 2025
Thyrocare Technologies Revenue
Thyrocare Technologies had revenue of 1.93B INR in the quarter ending June 30, 2025, with 23.02% growth. This brings the company's revenue in the last twelve months to 7.23B, up 21.82% year-over-year. In the fiscal year ending March 31, 2025, Thyrocare Technologies had annual revenue of 6.87B with 20.19% growth.
Revenue (ttm)
7.23B
Revenue Growth
+21.82%
P/S Ratio
10.14
Revenue / Employee
3.97M
Employees
1,822
Market Cap
73.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.87B | 1.15B | 20.19% |
Mar 31, 2024 | 5.72B | 452.20M | 8.59% |
Mar 31, 2023 | 5.27B | -621.90M | -10.56% |
Mar 31, 2022 | 5.89B | 942.40M | 19.05% |
Mar 31, 2021 | 4.95B | 603.60M | 13.90% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,839.41B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Infosys | 1,672.76B |
Hindustan Unilever | 639.28B |
Thyrocare Technologies News
- 26 days ago - Thyrocare shares rally over 7% as Q1 net profit rises 62% YoY Rs 38.06 crore, revenue up 23% YoY - Business Upturn
- 27 days ago - Thyrocare Technologies Q1 Results: Net profit jumps 62% YoY Rs 38.06 crore, revenue up 23% YoY - Business Upturn
- 4 months ago - Thyrocare Technologies Q4 results: Revenue up 21% YoY to Rs 187.2 crore, PAT jumps 88% YoY; Board recommends Rs 21 dividend per share - Business Upturn
- 7 months ago - Thyrocare Technologies Q3 FY25 Results: Revenue jumps 23.2% YoY to Rs 165.9 crore, Net Profit surges 24% YoY - Business Upturn
- 11 months ago - Thyrocare completes acquisition of Vimta Labs’ Diagnostic business - Business Upturn